BioSpace News Archive

Aravive, Inc. (Nasdaq: ARAV), a late clinical-stage oncology company developing targeted therapeutics to treat metastatic disease, today announced positive new data from the Phase 1b portion of the ongoing Phase 1b/2 trial of batiraxcept in clear cell renal cell cancer (ccRCC) and new data from a biomarker high subgroup.

CareDx, Inc. announced that its strategic partner, Cibiltech, a French MedTech company that develops artificial intelligence-based products for predictive medicine, has initiated the CIBIL clinical trial to evaluate the performance of iBox artificial intelligence as a prognostic measure of organ survival in kidney transplant patients.

EyePoint Pharmaceuticals, Inc. today announced financial results for the fourth quarter and year ended December 31, 2021 and highlighted recent corporate developments.

Lantern Pharma announced today that it will host a conference call on Thursday, March 10th, 2022 at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time.

BioLineRx Ltd. today announced additional positive results from a follow-on pharmacoeconomic study that was performed based on data from the Company’s successful Phase 3 GENESIS trial.

Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company focused on revolutionizing product discovery and development in multiple life-science based industries, today announced that it will present at the 34th Annual ROTH Conference being held both virtually and in-person in Dana Point, California on March 13-15, 2022.

PREDICT Registry Meets Phase One Accrual Goal of 2,500 Patients; Largest Ongoing Prospective Ductal Carcinoma in Situ Study in the World.

Sutro Biopharma, Inc. (“Sutro” or the “Company”) (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation cancer therapeutics, today announced that Bill Newell, Chief Executive Officer, will participate in the Ovarian Cancer Panel at the Cowen 42nd Annual Healthcare Conference.

Unicycive Therapeutics, Inc. today announced that Shalabh Gupta , M.D., Chief Executive Officer of Unicycive, will participate at two upcoming investor conferences in March.

Civica, Inc. (Civica, Civica Rx) today announced plans to manufacture and distribute insulins that, once approved, will be available to people with diabetes at significantly lower prices than insulins currently on the market.